COVID‐19 vaccination hesitancy among people with chronic neurological disorders: A position paper

BACKGROUND AND PURPOSE: Health risks associated with SARS‐CoV‐2 infection are undisputed. Moreover, the capability of vaccination to prevent symptomatic, severe, and fatal COVID‐19 is recognized. There is also early evidence that vaccination can reduce the chance for long COVID‐19. Nonetheless, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Rakusa, Martin, Öztürk, Serefnur, Moro, Elena, Helbok, Raimund, Bassetti, Claudio L., Beghi, Ettore, Bereczki, Daniel, Bodini, Benedetta, Di Liberto, Giovanni, Jenkins, Thomas M., Macerollo, Antonella, Maia, Luis F., Martinelli‐Boneschi, Filippo, Pisani, Antonio, Priori, Alberto, Sauerbier, Anna, Soffietti, Riccardo, Taba, Pille, von Oertzen, Tim J., Zedde, Marialuisa, Crean, Michael, Burlica, Anja, Cavallieri, Francesco, Sellner, Johann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
All Neurologists
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111566/
https://www.ncbi.nlm.nih.gov/pubmed/35460319
http://dx.doi.org/10.1111/ene.15368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111566/
https://www.ncbi.nlm.nih.gov/pubmed/35460319
http://dx.doi.org/10.1111/ene.15368

Ejemplares similares